PancreaCell

PancreaCell is a regenerative medicine company focused on restoring pancreatic function and treating diabetes and pancreatic cancer. As a startup within the Leonhardt Ventures ecosystem, the company utilizes a proprietary bioelectric stimulation platform to trigger the controlled release of specific regenerative proteins on demand. This technology is integrated with an implantable micro-infusion pump that delivers the 'PC-15' cocktail, a complex mixture of stem cells, growth factors, and microRNAs. By combining bioelectric signaling with targeted cell therapy, PancreaCell aims to regenerate failing pancreatic tissue and restore natural insulin production. The company's approach also includes specific bioelectric signals designed to inhibit tumor growth and blood supply in pancreatic cancer cases.